RxDoctor Payments Data

Jeremy Spaulding

Podiatrist · Indianapolis, INNPI 1093988263

Payments from drug & device makers

What this record shows

The money is spread across several categories — food and beverage (47.8%), consulting fees and speaking fees — rather than concentrated in one kind of arrangement. 31 manufacturers reported payments, led by Osteomed LLC at 52.2% of the total. Reporting peaked in 2020 at $1,091 and has fallen 81.8% since, to $198 in 2025.

$3,830in general payments, 2019–2025

Across 77 payments — averaging $49.74 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Osteomed LLC$2K
  • Zimmer Biomet$276
  • Organogenesis Inc.$211
  • Stryker$206
  • Amgen$178
  • Next Science LLC$149
  • plus $809 from 25 others

What the payments were for

  • Consulting fees$1,00026%
  • Speaking & faculty fees$1,00026%
  • Food & beverage$1,83048%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,830 in reported general payments places this provider in the 70th percentile of 131 podiatrist providers in Indiana.

See all podiatrist providers in Indiana

Medicare billing

Part B allowed, 2024
$151,834
Medicare patients
526
Services billed
2,099

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Doxycycline Hyclate103$1,007
Terbinafine Hcl45$861
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen73$431
Gabapentin53$428
Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen28$402
Cephalexin55$402
Ammonium Lactate23$324
Prednisone63$294
Clindamycin Hcl30$289
Ciclopirox13$281
Meloxicam47$120
Zolpidem Tartrate11$38
Penicillin V Potassium20$29

Paid to pharmacies, not to this prescriber.

Other podiatrist in Indianapolis

See the full list for Indiana

Where these figures come from

Is this you, or does something look wrong? →